K Sudo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
K Sudo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
K Konno
Rational Drug Design Laboratories, 4-1-1, Misato, Matsukawa-Machi, Fukushima 960–12, Japan
2 shared publicationsT Yokota
Rational Drug Design Laboratories, 4-1-1, Misato, Matsukawa-Machi, Fukushima 960–12, Japan
2 shared publicationsK Shimotohno
Institute for Virus Research, Kyoto University, Sakyo-ku Shogoin, Kyoto 606, Japan
1 shared publicationM Matsushima
Rational Drug Design Laboratories, 4-1-1, Misato, Matsukawa-Machi, Fukushima 960-1 2, Japan
1 shared publicationS Shigeta
Department of Microbiology, Fukushima Medical College, 1 Hikarigaoka, Fukushima 960–12, Japan
1 shared publication- S. Shigeta
Department of Microbiology, School of Medicine, Fukushima Medical University, Japan
1 shared publication
Latest Publications
- Open Access
- 1 June 1998
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 9 (3) , 263-267
Inhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication
Podophyllotoxin and its derivatives were examined for inhibitory effects on the replication of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), including acyclovir-resistant virus and clinical isolates. Deoxypodophyllotoxin (RD4–6266) proved to be a highly potent and selective inhibitor of all HSV strains in MRC-5 cells. EC50 values of RD4–6283 (in which the methylenedioxy ring A is modified) for HSV-1 and -2 were inferior to those of deoxypodophyllotoxin. However, podorhizol (RD4–6277) and 5′-methoxy-podorhizol (RD4–6276), in which ring C is absent, did notinhibit HSV replication. Moreover, RD4–6266 also inhibited the production of infectious virus particles of HSV-1 KOS strain and HSV-2 G strain. In contrast, none of the podophyllotoxin derivatives were found to have an antiviral effect against influenza A virus, respiratory syncytial virus or human cytomegalovirus in doses not toxic to the cells.
- 1 June 1998
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 9 (3) , 263-267
Open AccessInhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication
Podophyllotoxin and its derivatives were examined for inhibitory effects on the replication of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), including acyclovir-resistant virus and clinical isolates. Deoxypodophyllotoxin (RD4–6266) proved to be a highly potent and selective inhibitor of all HSV strains in MRC-5 cells. EC50 values of RD4–6283 (in which the methylenedioxy ring A is modified) for HSV-1 and -2 were inferior to those of deoxypodophyllotoxin. However, podorhizol (RD4–6277) and 5′-methoxy-podorhizol (RD4–6276), in which ring C is absent, did notinhibit HSV replication. Moreover, RD4–6266 also inhibited the production of infectious virus particles of HSV-1 KOS strain and HSV-2 G strain. In contrast, none of the podophyllotoxin derivatives were found to have an antiviral effect against influenza A virus, respiratory syncytial virus or human cytomegalovirus in doses not toxic to the cells.
- Open Access
- 1 December 1997
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 8 (6) , 541-544
Novel Hepatitis C virus Protease Inhibitors: 2,4,6-Trihydroxy,3-Nitro-Benzamide Derivatives
This study evaluated the inhibitory effects of 2,4,6-trihydroxy,3-nitro-benzamide (THNB) derivatives against hepatitis C virus (HCV). protease and other human serine proteases. The inhibitory efficacy was tested with a reversed-phase HPLC assay system using a NS3-NS4A fusion protein as the HCV protease and a synthetic peptide substrate that mimics the NS5A-5B junction. Twelve THNB derivatives showed more than 50% inhibition at 100 μg mL-1. The most potent derivative was RD3-4082, with 50% inhibition at a concentration of 2.3 μg mL-1; this concentration was lower than those of other protease inhibitors reported previously. The most selective derivative was RD2-4039, with 50% inhibition at a concentration of 32.8 μg mL-1, a lower concentration than those against other serine proteases (chymotrypsin, trypsin, plasmin and elastase). These results suggest that the RD2-4039 skeleton is an important structure for inhibitory activity against the HCV protease NS3-NS4A.
- 1 December 1997
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 8 (6) , 541-544
Open AccessNovel Hepatitis C virus Protease Inhibitors: 2,4,6-Trihydroxy,3-Nitro-Benzamide Derivatives
This study evaluated the inhibitory effects of 2,4,6-trihydroxy,3-nitro-benzamide (THNB) derivatives against hepatitis C virus (HCV). protease and other human serine proteases. The inhibitory efficacy was tested with a reversed-phase HPLC assay system using a NS3-NS4A fusion protein as the HCV protease and a synthetic peptide substrate that mimics the NS5A-5B junction. Twelve THNB derivatives showed more than 50% inhibition at 100 μg mL-1. The most potent derivative was RD3-4082, with 50% inhibition at a concentration of 2.3 μg mL-1; this concentration was lower than those of other protease inhibitors reported previously. The most selective derivative was RD2-4039, with 50% inhibition at a concentration of 32.8 μg mL-1, a lower concentration than those against other serine proteases (chymotrypsin, trypsin, plasmin and elastase). These results suggest that the RD2-4039 skeleton is an important structure for inhibitory activity against the HCV protease NS3-NS4A.